Replies to post #325269 on Amarin Corp Plc (AMRN)

[north40000]

Yep, again—169k shares were enjoying the
FDA fast-track given to Brilacidin until a modest share price decline this past week; closed at $0.34. Market value of our shares = $57,460.

Brilacidin could be given an EUA by FDA if clinical trial results warrant such. IMO, the same is true for Vascepa.

I had my 2nd shot of PFE vaccine 2 days ago. Its effectiveness may be confounded by any effect from Vascepa. I recall Dr. Bhatt saying at NLA that Vascepa might prevent any virus, including COVID-19, from establishing a home in some (all?) human systems where it might mutate and reproduce. Early trial results from Bhatt et al no later than March; Argentina and Kaiser results should ensue by mid-year.